TSC1 and nonpapillary renal cell carcinoma: In a mouse model of ccRCC (Gu et al., 2017), co-targeting of VHL and PBRM1 led to low grade ccRCC tumors that arose late, while an aggressive phenotype was triggered by the additional disruption of TSC1, a component of the PI3K pathway.